Journal of Structural Heart Disease, April 2019, Volume 5, Issue 2:43-47
Patent Foramen Ovale Closure using Cardioform Occluder Device Through the Right Internal Jugular Vein for Primary Prevention (First in Man): Importance of a Multidisciplinary Team
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
Percutaneous transcatheter closure of Patent Foramen Ovale (PFO) is usually performed via the femoral vein but in certain circumstances, this approach may not be possible necessitating the need for an alternative access. The right internal jugular vein has been successfully utilized in these cases. We are presenting the first successful PFO closure using a Cardioform Occluder Device to close a PFO as a primary prevention approach in a patient with a large inferior vena cava thrombus from renal cell carcinoma.
Cite this article as: Al Danaf J, Saidi A, Smith B, Tandar A. Patent Foramen Ovale Closure using Cardioform Occluder Device Through the Right Internal Jugular Vein for Primary Prevention (First in Man): Importance of a Multidisciplinary Team. Structural Heart Disease 2019;5(2):43-47. DOI: 10.12945/j.jshd.2019.019.18
You must be registered and logged in to leave comments.
There have been no comments posted yet
All comments will be screened and reviewed before posting. Statements, opinions, and results of studies published in Journal of Structural Heart Disease are those of the authors and do not reflect the policy or position of The Journal and Science International and the Editorial Board and provides no warranty as to their accuracy or reliability. Material is copyrighted and owned by Science International and cannot be used without expressed permission.